Healthcare Cost Debate in the House Budget Committee
Republicans and Democrats Clash Over Healthcare Costs
On Wednesday, members of the House Budget Committee from both the Republican and Democratic parties engaged in a heated discussion, attributing the rising costs of healthcare to one another while promoting opposing strategies to address the issue. Despite the tensions, some bipartisan consensus emerged, particularly concerning healthcare consolidation—a stance that is gaining traction among GOP members.
Bipartisan Agreement on Healthcare Consolidation
Chairman Jodey Arrington, R-Texas, highlighted the issue of consolidation, stating, “We got problems in Peoria with consolidation, with too much power and too many assets in too few market participants.” Arrington emphasized the importance of finding common ground, noting, “We ought to huddle up at some point, probably not during a hearing, and figure out where we can deal with big medicine monopolies in pharma, hospital, insurance — the whole gambit. And I just want you to know I’m down with that.”
Democrats have long criticized corporate consolidation, asserting that excessive mergers lead to higher prices for consumers by stifling competition. The GOP’s alignment with this viewpoint marks a significant shift, reflecting the party’s increasing populist tendencies influenced by former President Donald Trump’s MAGA movement.
Public Pressure to Address Rising Healthcare Costs
With the expiration of more generous financial assistance for Affordable Care Act (ACA) plans at the end of 2025, Republicans are under pressure to reduce healthcare costs. Over 20 million Americans who receive subsidies are facing substantial premium increases this year, with around 4 million expected to become uninsured. This situation adds urgency to the broader conversation regarding the escalating healthcare expenses in the U.S.
Recent data from the Centers for Medicare & Medicaid Services (CMS) indicates that U.S. health spending reached $5.3 trillion in 2024, marking a 7.2% increase from the previous year. Additionally, healthcare’s share of the national economy rose from 17.7% in 2023 to 18% in 2024. Benedic Ippolito, a senior fellow at the American Enterprise Institute, remarked, “That is by no measure sustainable in the long run.”
The Impact of Consolidation on Healthcare Spending
Experts at the hearing identified consolidation as a primary factor driving up healthcare costs. The U.S. healthcare sector has become increasingly consolidated, with a few dominant health systems or insurers controlling a significant portion of markets in various regions. This concentration correlates directly with higher prices without corresponding improvements in patient outcomes.
According to a MedPAC analysis and research from the Urban Institute, 90% of hospital markets were highly concentrated as of 2017, with indications that this trend has continued. Furthermore, the ten largest insurers now cover over half of all enrollees in private insurance, Medicaid, and privatized Medicare, based on findings from the KFF and the Peterson Center on Healthcare.
Calls to Break Up Healthcare Monopolies
Joel White, president of the Council for Affordable Health Coverage, testified, “Congress must start by breaking up the monopolies. Market consolidation is foundationally increasing prices in almost every area of the country.” In agreement, Rep. Becca Balint, D-Vt., stated, “We got to break up the monopolies. I couldn’t agree with you more. Why are we not taking on the monopolies? I look forward to actually doing that work.”
Democrats have previously introduced legislation aimed at addressing market concentration in healthcare, including the “Stop Anticompetitive Healthcare Act,” which seeks to empower the Federal Trade Commission to oversee nonprofit hospital mergers, and the “Patients Before Monopolies Act,” which would prevent pharmacy benefit managers from owning pharmacies. Notably, both bills have garnered Republican co-sponsors.
Future Challenges and Potential Solutions
Rep. Pramila Jayapal, D-Wash., acknowledged the shared concern about consolidation within the healthcare system during the hearing. However, dismantling healthcare conglomerates presents significant challenges. Other areas of bipartisan support, such as enhancing price transparency and addressing the discrepancies in medical costs across care settings, may offer more immediate opportunities for legislative action. Congress is expected to vote on a funding agreement that includes reforms related to pharmacy benefit managers later this month. Nevertheless, experts caution that such incremental measures may not be sufficient to substantially improve healthcare affordability.